More on MAZE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Maze Therapeutics (NQ:MAZE)
Delayed: 44.83 -0.47 (1.04%)
Prev. Close $45.30  
Open$44.62 
52 Wk High$ 
52 Wk Low$ 
Day High$45.86 
Day Low$43.10 
P/E N/A  
EPS$ 
Volume383,490 

Friends, Peers and Foes (?): BCYC, AMGN, IRON, JNJ, LLY (more...)

Mar 3, 2026 05:31 PM Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Mar 3, 2026 04:46 PM Form 4 Maze Therapeutics, Inc. For: Feb 27 Filed by: Dandekar Atul
Mar 3, 2026 04:46 PM Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Bachrodt Amy
Mar 3, 2026 04:45 PM Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Bernstein Harold
Mar 3, 2026 04:42 PM Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Tahir Misbah
Mar 3, 2026 04:33 PM Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Courtney Phillips
Mar 3, 2026 04:25 PM Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Coloma Jason V
Feb 25, 2026 07:00 AM Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Feb 13, 2026 05:31 PM Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Feb 13, 2026 05:31 PM Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
View All Articles

Entities mentioned with MAZE

View All Entities